Status:
UNKNOWN
Coronary Revascularization Based on CMR Viability Study Vs Direct Revascularization in Ischemic Cardiomyopathy Patients
Lead Sponsor:
Assiut University
Conditions:
Ischemic Cardiomyopathy
Eligibility:
All Genders
18+ years
Brief Summary
The study aiming to demonstrate the baseline characteristics and outcomes of patients undergoing revascularization by PCI vs those kept only on medical treatment, based on CMR viability assessment.
Detailed Description
Cardiac magnetic resonance (CMR) has an ever-increasing role in the assessment and management of patients with coronary artery disease (CAD). Advantages of CMR include the lack of ionizing radiation a...
Eligibility Criteria
Inclusion
- Patients \>18 years of age, with LVEF\<40%.
- Patients presenting for viability assessment to Assiut university Heart Hospital, starting from October 2020 till September 2021, will be retrospectively recruited.
- Patients with a coronary angiography that is amenable for revascularization. The decision and type of revascularization will be determined by the treating physicians.
Exclusion
- Classic CMR and gadolinium-based dye contraindications including non-MRI compatible implants/foreign bodies (e.g. non-MRI compatible pacemaker, large pieces of shrapnel) and patients with eGFR\<30 ml/min/1.73 m2.
- Patients with non-ischemic cardiomyopathy confirmed by both CMR and coronary angiography.
Key Trial Info
Start Date :
February 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2023
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT05194865
Start Date
February 1 2022
End Date
July 1 2023
Last Update
January 18 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.